A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00620555 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsies, Partial

Interventions

DRUG: gabapentin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.